APO Research
Talk to an analyst

APO RESEARCH · REPORT

Personalized Psychiatry

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Personalized Psychiatry Market Outlook and Growth Opportunities 2026

3 May 2026197 pages

Choose your research edition.

Industry ResearchPersonalized Psychiatry Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Personalized Psychiatry Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Personalized Psychiatry Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Personalized Psychiatry Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Personalized Psychiatry Market Analysis and Forecast 2026-2032235 pages · $4,950 USD

Market perspective

The global Personalized Psychiatry market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Personalized Psychiatry is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Personalized Psychiatry market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Personalized Psychiatry market include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica and Akili Interactive, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Personalized Psychiatry market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Personalized Psychiatry and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Personalized Psychiatry revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Personalized Psychiatry market.

Personalized Psychiatry Segment by Company

COMPASS Pathways

Mindstrong Health

Pear Therapeutics

Cogito

Kaia Health

Sooma

GenoMind

Empatica

Akili Interactive

Neuroverse

Personalized Psychiatry Segment by Type

Depression and Anxiety

Bipolar Disorder

Addiction

Other

Personalized Psychiatry Segment by Application

Mental Health Professionals

Patients

Healthcare Providers

Personalized Psychiatry Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Personalized Psychiatry status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Personalized Psychiatry key companies, revenue, market share, and recent developments.

3. To split the Personalized Psychiatry breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Personalized Psychiatry market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Personalized Psychiatry significant trends, drivers, influence factors in global and regions.

6. To analyze Personalized Psychiatry competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Personalized Psychiatry market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Personalized Psychiatry and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Personalized Psychiatry.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Personalized Psychiatry industry.

Chapter 3: Detailed analysis of Personalized Psychiatry company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Personalized Psychiatry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Personalized Psychiatry in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Personalized Psychiatry Industry Trends Table 2. Personalized Psychiatry Industry Drivers Table 3. Personalized Psychiatry Industry Opportunities and Challenges Table 4. Personalized Psychiatry Industry Restraints Table 5. Global Personalized Psychiatry Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Personalized Psychiatry Revenue Share by Company (2021-2026) Table 7. Global Personalized Psychiatry Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Personalized Psychiatry Key Company Manufacturing Base & Headquarters Table 9. Global Personalized Psychiatry Company, Product Type & Application Table 10. Global Personalized Psychiatry Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Personalized Psychiatry by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Depression and Anxiety Table 15. Significant Companies of Bipolar Disorder Table 16. Significant Companies of Addiction Table 17. Significant Companies of Other Table 18. Global Personalized Psychiatry Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Personalized Psychiatry Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Personalized Psychiatry Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Personalized Psychiatry Sales Value Share by Type (2021-2026) Table 22. Global Personalized Psychiatry Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Mental Health Professionals Table 24. Significant Companies of Patients Table 25. Significant Companies of Healthcare Providers Table 26. Global Personalized Psychiatry Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Personalized Psychiatry Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Personalized Psychiatry Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Personalized Psychiatry Sales Value Share by Application (2021-2026) Table 30. Global Personalized Psychiatry Sales Value Share by Application (2027-2032) Table 31. Global Personalized Psychiatry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Personalized Psychiatry Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Personalized Psychiatry Sales Value Share by Region (2021-2026) Table 34. Global Personalized Psychiatry Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Personalized Psychiatry Sales Value Share by Region (2027-2032) Table 36. Global Personalized Psychiatry Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Personalized Psychiatry Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Personalized Psychiatry Sales Value Market Share by Country (2021-2026) Table 39. Global Personalized Psychiatry Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Personalized Psychiatry Sales Value Market Share by Country (2027-2032) Table 41. COMPASS Pathways Company Information Table 42. COMPASS Pathways Business Overview Table 43. COMPASS Pathways Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. COMPASS Pathways Personalized Psychiatry Product Portfolio Table 45. COMPASS Pathways Recent Development Table 46. Mindstrong Health Company Information Table 47. Mindstrong Health Business Overview Table 48. Mindstrong Health Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Mindstrong Health Personalized Psychiatry Product Portfolio Table 50. Mindstrong Health Recent Development Table 51. Pear Therapeutics Company Information Table 52. Pear Therapeutics Business Overview Table 53. Pear Therapeutics Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Pear Therapeutics Personalized Psychiatry Product Portfolio Table 55. Pear Therapeutics Recent Development Table 56. Cogito Company Information Table 57. Cogito Business Overview Table 58. Cogito Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Cogito Personalized Psychiatry Product Portfolio Table 60. Cogito Recent Development Table 61. Kaia Health Company Information Table 62. Kaia Health Business Overview Table 63. Kaia Health Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Kaia Health Personalized Psychiatry Product Portfolio Table 65. Kaia Health Recent Development Table 66. Sooma Company Information Table 67. Sooma Business Overview Table 68. Sooma Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sooma Personalized Psychiatry Product Portfolio Table 70. Sooma Recent Development Table 71. GenoMind Company Information Table 72. GenoMind Business Overview Table 73. GenoMind Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. GenoMind Personalized Psychiatry Product Portfolio Table 75. GenoMind Recent Development Table 76. Empatica Company Information Table 77. Empatica Business Overview Table 78. Empatica Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Empatica Personalized Psychiatry Product Portfolio Table 80. Empatica Recent Development Table 81. Akili Interactive Company Information Table 82. Akili Interactive Business Overview Table 83. Akili Interactive Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Akili Interactive Personalized Psychiatry Product Portfolio Table 85. Akili Interactive Recent Development Table 86. Neuroverse Company Information Table 87. Neuroverse Business Overview Table 88. Neuroverse Personalized Psychiatry Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Neuroverse Personalized Psychiatry Product Portfolio Table 90. Neuroverse Recent Development Table 91. Research Programs/Design for This Report Table 92. Authors List of This Report Table 93. Secondary Sources Table 94. Primary Sources List of Figures Figure 1. Personalized Psychiatry Product Image Figure 2. Global Personalized Psychiatry Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Personalized Psychiatry Market Size (2021-2032) & (US$ Million) Figure 4. Global Personalized Psychiatry Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Depression and Anxiety Image Figure 8. Bipolar Disorder Image Figure 9. Addiction Image Figure 10. Other Image Figure 11. Global Personalized Psychiatry Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Personalized Psychiatry Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Personalized Psychiatry Sales Value Share by Type (2021-2032) Figure 14. Mental Health Professionals Image Figure 15. Patients Image Figure 16. Healthcare Providers Image Figure 17. Global Personalized Psychiatry Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Personalized Psychiatry Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Personalized Psychiatry Sales Value Share by Application (2021-2032) Figure 20. Global Personalized Psychiatry Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Personalized Psychiatry Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Personalized Psychiatry Sales Value (2021-2032) & (US$ Million) Figure 23. North America Personalized Psychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Personalized Psychiatry Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Personalized Psychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Personalized Psychiatry Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Personalized Psychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Personalized Psychiatry Sales Value (2021-2032) & (US$ Million) Figure 29. South America Personalized Psychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Personalized Psychiatry Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Personalized Psychiatry Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Personalized Psychiatry Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Depression and Anxiety
  • Bipolar Disorder
  • Addiction
  • Other
Applications
  • Mental Health Professionals
  • Patients
  • Healthcare Providers
Companies covered
  • COMPASS Pathways
  • Mindstrong Health
  • Pear Therapeutics
  • Cogito
  • Kaia Health
  • Sooma
  • GenoMind
  • Empatica
  • Akili Interactive
  • Neuroverse

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Personalized Psychiatry Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Personalized Psychiatry Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Personalized Psychiatry Market Dynamics
  1. 2.1 Personalized Psychiatry Industry Trends
  2. 2.2 Personalized Psychiatry Industry Drivers
  3. 2.3 Personalized Psychiatry Industry Opportunities and Challenges
  4. 2.4 Personalized Psychiatry Industry Restraints
3 Personalized Psychiatry Market by Company
  1. 3.1 Global Personalized Psychiatry Company Revenue Ranking in 2025
  2. 3.2 Global Personalized Psychiatry Revenue by Company (2021-2026)
  3. 3.3 Global Personalized Psychiatry Company Ranking (2024-2026)
  4. 3.4 Global Personalized Psychiatry Company Manufacturing Base and Headquarters
  5. 3.5 Global Personalized Psychiatry Company Product Type and Application
  6. 3.6 Global Personalized Psychiatry Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Personalized Psychiatry Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Personalized Psychiatry Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Personalized Psychiatry Market by Type
  1. 4.1 Personalized Psychiatry Type Introduction
  2. 4.1.1 Depression and Anxiety
  3. 4.1.2 Bipolar Disorder
  4. 4.1.3 Addiction
  5. 4.1.4 Other
  6. 4.2 Global Personalized Psychiatry Sales Value by Type
  7. 4.2.1 Global Personalized Psychiatry Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Personalized Psychiatry Sales Value by Type (2021-2032)
  9. 4.2.3 Global Personalized Psychiatry Sales Value Share by Type (2021-2032)
5 Personalized Psychiatry Market by Application
  1. 5.1 Personalized Psychiatry Application Introduction
  2. 5.1.1 Mental Health Professionals
  3. 5.1.2 Patients
  4. 5.1.3 Healthcare Providers
  5. 5.2 Global Personalized Psychiatry Sales Value by Application
  6. 5.2.1 Global Personalized Psychiatry Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Personalized Psychiatry Sales Value by Application (2021-2032)
  8. 5.2.3 Global Personalized Psychiatry Sales Value Share by Application (2021-2032)
6 Personalized Psychiatry Regional Value Analysis
  1. 6.1 Global Personalized Psychiatry Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Personalized Psychiatry Sales Value by Region (2021-2032)
  3. 6.2.1 Global Personalized Psychiatry Sales Value by Region: 2021-2026
  4. 6.2.2 Global Personalized Psychiatry Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Personalized Psychiatry Sales Value (2021-2032)
  7. 6.3.2 North America Personalized Psychiatry Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Personalized Psychiatry Sales Value (2021-2032)
  10. 6.4.2 Europe Personalized Psychiatry Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Personalized Psychiatry Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Personalized Psychiatry Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Personalized Psychiatry Sales Value (2021-2032)
  16. 6.6.2 South America Personalized Psychiatry Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Personalized Psychiatry Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Personalized Psychiatry Sales Value Share by Country, 2025 VS 2032
7 Personalized Psychiatry Country-level Value Analysis
  1. 7.1 Global Personalized Psychiatry Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Personalized Psychiatry Sales Value by Country (2021-2032)
  3. 7.2.1 Global Personalized Psychiatry Sales Value by Country (2021-2026)
  4. 7.2.2 Global Personalized Psychiatry Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Personalized Psychiatry Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Personalized Psychiatry Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Personalized Psychiatry Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 COMPASS Pathways
  2. 8.1.1 COMPASS Pathways Company Information
  3. 8.1.2 COMPASS Pathways Business Overview
  4. 8.1.3 COMPASS Pathways Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  5. 8.1.4 COMPASS Pathways Personalized Psychiatry Product Portfolio
  6. 8.1.5 COMPASS Pathways Recent Developments
  7. 8.2 Mindstrong Health
  8. 8.2.1 Mindstrong Health Company Information
  9. 8.2.2 Mindstrong Health Business Overview
  10. 8.2.3 Mindstrong Health Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mindstrong Health Personalized Psychiatry Product Portfolio
  12. 8.2.5 Mindstrong Health Recent Developments
  13. 8.3 Pear Therapeutics
  14. 8.3.1 Pear Therapeutics Company Information
  15. 8.3.2 Pear Therapeutics Business Overview
  16. 8.3.3 Pear Therapeutics Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pear Therapeutics Personalized Psychiatry Product Portfolio
  18. 8.3.5 Pear Therapeutics Recent Developments
  19. 8.4 Cogito
  20. 8.4.1 Cogito Company Information
  21. 8.4.2 Cogito Business Overview
  22. 8.4.3 Cogito Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cogito Personalized Psychiatry Product Portfolio
  24. 8.4.5 Cogito Recent Developments
  25. 8.5 Kaia Health
  26. 8.5.1 Kaia Health Company Information
  27. 8.5.2 Kaia Health Business Overview
  28. 8.5.3 Kaia Health Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Kaia Health Personalized Psychiatry Product Portfolio
  30. 8.5.5 Kaia Health Recent Developments
  31. 8.6 Sooma
  32. 8.6.1 Sooma Company Information
  33. 8.6.2 Sooma Business Overview
  34. 8.6.3 Sooma Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sooma Personalized Psychiatry Product Portfolio
  36. 8.6.5 Sooma Recent Developments
  37. 8.7 GenoMind
  38. 8.7.1 GenoMind Company Information
  39. 8.7.2 GenoMind Business Overview
  40. 8.7.3 GenoMind Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GenoMind Personalized Psychiatry Product Portfolio
  42. 8.7.5 GenoMind Recent Developments
  43. 8.8 Empatica
  44. 8.8.1 Empatica Company Information
  45. 8.8.2 Empatica Business Overview
  46. 8.8.3 Empatica Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Empatica Personalized Psychiatry Product Portfolio
  48. 8.8.5 Empatica Recent Developments
  49. 8.9 Akili Interactive
  50. 8.9.1 Akili Interactive Company Information
  51. 8.9.2 Akili Interactive Business Overview
  52. 8.9.3 Akili Interactive Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Akili Interactive Personalized Psychiatry Product Portfolio
  54. 8.9.5 Akili Interactive Recent Developments
  55. 8.10 Neuroverse
  56. 8.10.1 Neuroverse Company Information
  57. 8.10.2 Neuroverse Business Overview
  58. 8.10.3 Neuroverse Personalized Psychiatry Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Neuroverse Personalized Psychiatry Product Portfolio
  60. 8.10.5 Neuroverse Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst